Episode: 167 - M&A, IPO or SPAC: CEOs Share Exit Strategies and Lessons Learned Along the Way
Podcast |
Medtech Talk
Publisher |
Healthegy
Media Type |
audio
Podknife tags |
Business
Health
Investing
Technology
Categories Via RSS |
Business
Investing
Publication Date |
Apr 19, 2022
Episode Duration |
01:01:32

Geoff Pardo and three successful medtech CEOs who exited their companies through a different pathway— M&A, IPO, and SPAC—discuss the pros and cons of each. While market volatility is a given, Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical; Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth; and Leslie Trigg, CEO, Outset Medical agreed that successful CEOs keep their focus on delivering returns for their investors—whether private or public. If your company is solving a really important problem and is creating value for patients, you’ll ultimately succeed, Shook said. From there, Trigg pointed out, exit vehicles are simply different modes of transportation to the same place.  GUESTS:Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth Leslie Trigg, CEO, Outset Medical, Inc. 

HOST:  Geoff Pardo, General Partner, Gilde Healthcare; Host, Medtech Talk podcast  

LINKS:Cambridge Healthtech Institute Medtech Talk Gilde Healthcare OrangeTwist Outset Medical 

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review